Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 40)
9 November 2025
Merck's Enlicitide Decanoate Cuts LDL-C in HeFH Patients in Phase 3 Trial
Enlicitide decanoate shows significant LDL-C reduction in HeFH patients, with a safety profile similar to placebo, in the CORALreef HeFH trial.
7 November 2025
Takeda's Mezagitamab Maintains Kidney Function in IgAN After 18 Months
Mezagitamab shows stable eGFR, reduced proteinuria, and no serious adverse events in IgAN patients 18 months post-treatment; Phase 3 trials are underway.
7 November 2025
Novamont's Mater-Bi Mulch Film Certified as EU Inorganic Soil Improver
Mater-Bi mulch film is biodegradable, doesn't release microplastics, and meets EU standards, aiding soil health and reducing agricultural plastic waste.
7 November 2025
Tapì Group Partners with Trinseo for Sustainable Closures
Tapì integrates Trinseo's recycled PMMA in closures, enhancing sustainability and local collaboration in Italy's supply chain.
7 November 2025
AGC's Reflective Blade Wins CES 2026 Innovation Award
Reflective Blade projects driver info clearly, even with polarized sunglasses, offers flexible integration, and enhances user experience with a sleek design.
6 November 2025
Boehringer Ingelheim's Apecotrep Reduces Proteinuria in Phase II Kidney Trial
Apecotrep, a TRPC6 inhibitor, showed 40% proteinuria reduction in FSGS patients. Phase III trial recruiting; further Phase II trials planned for other kidney diseases.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
6 November 2025
Sasol Develops Methane Rich Gas Solution for South Africa's Post-2028 Gas Supply
Sasol plans to supply Methane Rich Gas from 2028-2030 to bridge South Africa's gas supply gap, pending regulatory approval, while transitioning to LNG for long-term needs.
6 November 2025
Perstorp Showcases Sustainable Liquid Cooling at OCP Summit
PFAS-free, biodegradable liquid cooling solutions are advancing from innovation to adoption, offering safer, efficient, and sustainable options for data centers.
6 November 2025
Lhyfe Secures Hydrogen Supply Deal with German Service Station Operator
Lhyfe will supply 90 tons of RFNBO-certified hydrogen over 15 months to fuel a fleet of buses in Germany, supporting green hydrogen's role in decarbonizing heavy mobility.
6 November 2025
PureCycle Technologies Q3 2025 Update
Record production, expanded product portfolio, and increased sales pipeline. Ironton compounding to boost capacity. Thailand project progresses. €40M EU grant application accepted.
6 November 2025
Johnson & Johnson's DARZALEX FASPRO®: First FDA-Approved Treatment for High-Risk Smoldering Multiple Myeloma
DARZALEX FASPRO® reduces progression risk to active multiple myeloma by 51% in high-risk patients, marking a shift in treatment strategy.
6 November 2025
Novo Nordisk's CagriSema Reduces Blood Pressure and Inflammation, Lowers Heart Disease Risk
CagriSema shows potential in reducing blood pressure, inflammation, and heart disease risk, with ongoing trials to assess cardiovascular outcomes.
6 November 2025
Lilly's Eloralintide Shows Promising Weight Loss in Phase 2 Obesity Study
Eloralintide led to significant weight loss and improved cardiometabolic factors in a Phase 2 trial, prompting Phase 3 studies for obesity treatment.
6 November 2025
Johnson & Johnson's CAPLYTA® Approved by FDA for Major Depressive Disorder Treatment
FDA approves CAPLYTA® as adjunctive therapy for major depressive disorder, showing significant symptom improvement and safety in trials, with potential for remission.
6 November 2025
EU Progresses on 2030 Climate Goals with Emission Reductions
The EU cuts emissions by 2.5% in 2024, driven by energy sector efforts. Investments and policies aim to meet 2030 targets, enhance climate resilience, and support global climate action.
6 November 2025
Topsoe Partners with NXTClean Fuels for Major U.S. SAF and Renewable Diesel Project
The project in Oregon will use Topsoe's technologies to produce 50,000 barrels/day of renewable diesel and SAF, aiming for operation by 2029, pending final investment decision.
6 November 2025
Clariant and FUHUA Form Joint Venture for Flame Retardants
The venture will produce halogen-free flame retardants in China, addressing regulatory needs. Clariant expands capacity with a CHF 100M investment and a new production line in Cangzhou.
6 November 2025
BASF Beauty Care Solutions Joins UEBT for Ethical Sourcing
Recognized for eco-conscious supply chains, BASF's Responsibly Active program emphasizes sustainable sourcing, biodiversity, and community empowerment in cosmetic bioactives.
6 November 2025
UPM Joins Cefic to Boost Renewable Chemistry in Europe
UPM aims to enhance Europe's chemical industry with renewable solutions, supporting innovation, sustainability, and industrial competitiveness.
6 November 2025
Heidelberg Materials Reports Q3 Growth, Confirms 2025 Outlook
Q3 results up 5%, operating margin at 25.9%. Transformation Accelerator boosts savings. CCS projects advance, with evoZero cement deliveries starting. 2025 outlook remains positive.
5 November 2025
TITAN and thyssenkrupp Polysius Partner on Low-Carbon Cement with meca® Clay Technology
The partnership aims to cut CO₂ in cement by using meca® clay to replace clinker, starting at TITAN's Patras plant, targeting a clinker-to-cement ratio below 40% by 2026.
5 November 2025
TITAN and thyssenkrupp Polysius Partner on Low-Carbon Cement with meca® Clay Technology
The partnership aims to cut CO₂ in cement production using meca® clay, reducing clinker use and supporting TITAN's goal for net-zero concrete by 2050.
5 November 2025
DuPont Awards Highlight Top PPE Innovations with Nomex® and Kevlar®
The awards recognize advancements in PPE for sustainability, multi-hazard protection, and firefighter safety using Nomex® and Kevlar® fabrics.
5 November 2025
Toray and Aichi Medical University Launch ALS Drug Research Initiative
The initiative uses a new evaluation technology to enhance ALS drug discovery, collaborating with pharmaceutical firms to improve treatment efficacy and accelerate R&D.
5 November 2025
Hyundai Transys and BASF Develop Modular Seat with Elastollan TPU
The new seat uses Elastollan TPU with SCF foaming for customizable, sustainable automotive interiors, offering recyclability, reduced VOCs, and energy efficiency.
5 November 2025
Novo Nordisk's Wegovy® Helps Users Meet Health Targets, Reducing Obesity Risks
Wegovy® users achieved BMI and waist targets, improving cardiovascular health and reducing obesity-related risks, as shown in the STEP UP trial.
5 November 2025
LyondellBasell Installs New Cast Film Line at Cincinnati Center
The new cast film line enhances innovation, enabling development of high-performance films and flexible applications, supporting customer collaboration and tailored solutions.
5 November 2025
Novo Nordisk Reports 12% Sales Growth in DKK, 15% at CER, and R&D Advances in First Nine Months of 2025
Operating profit rose 5% in DKK, 10% at CER. Obesity care sales up 37%. FDA approved Wegovy® for MASH. Novo Nordisk to acquire Akero Therapeutics. Full-year sales growth forecast at 8-11% CER.
5 November 2025
Novo Nordisk Unveils New Oral Semaglutide Analyses at ObesityWeek 2025
Oral semaglutide 25 mg shows improved blood sugar control, cardiovascular risk factors, and weight loss efficacy, comparable to injectable form, across various patient groups.
5 November 2025
TITAN and thyssenkrupp Polysius Partner on Low-Carbon Cement with meca® Clay Technology
The partnership aims to reduce CO₂ in cement production using meca® clay, targeting a clinker-to-cement ratio below 40% at TITAN's Patras plant, with pilot activities set for 2026.
← Previous
Next →
